Skip to main content
Dennis C. Shrieve

Dennis C. Shrieve, MD, PhD, FACR, FASTRO

Languages spoken: English, Spanish, French

Clinical Locations

  • Radiation Oncology

    801-581-2396
  • Dennis C. Shrieve, MD, PhD, is the Huntsman Cancer Institute Chair in Cancer Research and chair of the Department of Radiation Oncology at the University of Utah School of Medicine. He is a member of the Experimental Therapeutics Program at the Huntsman Cancer Institute and co-director of the Stereotactic Radiosurgery Program at the University.

    Shrieve is board certified by the American Board of Radiology in Radiation Oncology and has primary clinical research interests in adult and pediatric neuro-oncology, pediatric radiation oncology, and stereotactic radiotherapy. His basic research interests include intrinsic radiosensitivity of human tumors, the mechanisms of intrinsic cellular resistance to radiation and chemotherapy, and combined chemotherapy/radiotherapy.

    Shrieve serves on the Board of Trustees of the American Board of Radiology and is past-President of the International Stereotactic Radiosurgery Society. He has been listed in Best Doctors in America for over 10 years.

    Shrieve received his MD from the University of Miami and his PhD in radiation biophysics from the University of California at Berkeley. He served on the faculties of the University of California, San Francisco, and Harvard Medical School before coming to the University of Utah.

    Shrieve is the author or co-author of over 150 articles or book chapters in the medical and scientific literature. He co-editied the book "Human Radiation Injury" in 2010.

    Clinical areas of special expertise include pediatric brain tumors, adult brain tumors, stereotactic radiosurgery and treatment of brain metastases.

    Specialties

    Board Certification and Academic Information

    Academic Departments Radiation Oncology - Primary
  • Dennis C. Shrieve, MD, PhD, is the Huntsman Cancer Institute Chair in Cancer Research and chair of the Department of Radiation Oncology at the University of Utah School of Medicine. He is a member of the Experimental Therapeutics Program at the Huntsman Cancer Institute and co-director of the Stereotactic Radiosurgery Program at the University.

    Shrieve is board certified by the American Board of Radiology in Radiation Oncology and has primary clinical research interests in adult and pediatric neuro-oncology, pediatric radiation oncology, and stereotactic radiotherapy. His basic research interests include intrinsic radiosensitivity of human tumors, the mechanisms of intrinsic cellular resistance to radiation and chemotherapy, and combined chemotherapy/radiotherapy.

    Shrieve serves on the Board of Trustees of the American Board of Radiology and is past-President of the International Stereotactic Radiosurgery Society. He has been listed in Best Doctors in America for over 10 years.

    Shrieve received his MD from the University of Miami and his PhD in radiation biophysics from the University of California at Berkeley. He served on the faculties of the University of California, San Francisco, and Harvard Medical School before coming to the University of Utah.

    Shrieve is the author or co-author of over 150 articles or book chapters in the medical and scientific literature. He co-editied the book "Human Radiation Injury" in 2010.

    Clinical areas of special expertise include pediatric brain tumors, adult brain tumors, stereotactic radiosurgery and treatment of brain metastases.

    Board Certification and Academic Information

    Academic Departments Radiation Oncology -Primary

    Research interests

    • Adult and pediatric neuro-oncology
    • Pediatric Radiation Oncology
    • Conformal radiotherapy and radiosurgery for intracranial tumors of children and adults
    • Radiotherapy using altered fractionation in the treatment of pediatric and adult tumors
    • Combined chemoradiotherapy
    • Genitourinary malignancies
    • Intrinsic radiosensitivity of human tumors
    • Mechanisms of intrinsic cellular resistance to radiation and chemotherapy
    • Role of microenvironmental factors on cellular sensitivity to radiation and to chemotherapeutic agents
    • Mechanisms of normal tissue injury and repair following radiotherapy

    Education history

    Chief Resident Radiation Oncology - University of California - San Francisco Chief Resident
    Radiation Oncology - University of California - San Francisco Resident
    Internship Medicine - University of California - San Francisco Intern
    Medicine - University of Miami School of Medicine M.D.
    Postdoctoral Fellowship Research - Mount Vernon Hospital Postdoctoral Fellow
    Radiation Biophysics - University of California - Berkeley Ph.D.
    Undergraduate Zoology - University of California - Berkeley A.B.